Report: Potency of CBD Products Sold Online Often Deviates From What Is Advertised

Generic 8 November 2019 | 0 Comments

CBD-infused products sold online frequently possess significantly lower percentages of CBD than advertised, according to a report published by the online watchdog group LegitScript.com. Investigators lab-tested 30 CBD products obtained from leading online retailers. Twenty of the thirty products possessed significant deviations in CBD content as compared to what was advertised. Sixteen of the 20 […]

Tagged in , ,

Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators

Generic 22 October 2019 | 0 Comments

A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis. Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal […]

Tagged in , , ,

Why Dr. Sue Sisley Sued the DEA for Stonewalling Cannabis Research

Generic 21 September 2019 | 0 Comments

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. Dr. Sue Sisley I first met Dr. Sue Sisley in person when she spoke in Las Vegas a few years ago. Back then, Dr. Sisley just entered the national spotlight, known […]

Tagged in , , ,

Cannabis Vaping Concerns Call for Increased Regulations and Oversight

Generic 13 September 2019 | 0 Comments

The Trump administration is sounding the alarm against the manufacture and marketing of certain vape products at a time when health officials nationwide are scrambling to determine why some consumers are suddenly becoming sick from the use of certain vaping devices. But while the administration’s pending actions will no doubt influence commercial activities in the […]

Tagged in , , ,

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

Generic 27 August 2019 | 0 Comments

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. According to the agency’s filing today in the Federal Register, the DEA “intends to promulgate regulations” to evaluate several dozen applications before it from private entities that wish to cultivate cannabis for FDA-approved research. However, this […]

Tagged in , , ,